Quantcast
Home > Quotes > ADMA

ADMA Biologics Inc Common Stock (ADMA) Quote & Summary Data

ADMA 
$5.16
*  
0.13
2.58%
Get ADMA Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading ADMA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ADMA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
11
Today's High / Low
$ 5.18 / $ 5
Share Volume
81,282
50 Day Avg. Daily Volume
196,665
Previous Close
$ 5.03
52 Week High / Low
$ 6.96 / $ 2.42
Market Cap
239,163,492
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.44

Intraday Chart

Shares Traded

Share Volume:
81,282
50 Day Avg. Daily Volume:
196,665

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.31

Trading Range

The current last sale of $5.16 is 113.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.18 $ 6.96
 Low: $ 5 $ 2.42

Company Description (as filed with the SEC)

Unless the context otherwise requires, references in this Business section to "ADMA," "ADMA Biologics," the "Company," "we," "us" and "our" refer to ADMA Biologics, Inc., a Delaware corporation, as well as its wholly- owned and indirectly owned subsidiaries, ADMA Plasma Biologics, Inc., a Delaware corporation, ADMA Bio Centers Georgia Inc., a Delaware corporation ("ADMA BioCenters") and ADMA BioManufacturing, LLC, a Delaware limited liability company ("ADMA BioManufacturing"). Overview We are a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty plasma-derived biologics for the treatment of immune deficiencies and prevention of certain infectious diseases. Our targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons.  ... More ...  


Risk Grade

Where does ADMA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 5
Open Date:
Nov. 16, 2018
Close Price:
$ 5.03
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x